<DOC>
	<DOCNO>NCT00003092</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase III trial study effectiveness paclitaxel treat old patient solid tumor .</brief_summary>
	<brief_title>Paclitaxel Treating Older Patients With Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether relationship pharmacokinetic measurement paclitaxel age . - Determine whether relationship toxic effect paclitaxel age . OUTLINE : Patients stratify accord age ( cohort 1 : patient 55 64 v cohort 2 : patient 65 75 v cohort 3 : patient 75 ) .</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove nonhematologic malignancy PATIENT CHARACTERISTICS : Age : 55 Performance status : Zubrod 02 Life expectancy : Not specify Hematopoietic : Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL SGOT le 2.0 time upper limit normal ( ULN ) Renal : Creatinine great 1.5 time ULN Cardiovascular : No uncontrolled severe cardiovascular disease Other : No serious intercurrent medical illness judgement investigator compromise patient care No psychiatric condition would preclude study No requirement antibiotic active acute infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy ( 6 week nitrosoureas mitomycin ) No one prior chemotherapy regimen allow No prior paclitaxel allow Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiation therapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>